Transcatheter implantation of the aortic valve: transfemoral and transapical approach

    Authors

    Keywords

    aortic disease, transapical approach, transfemoral approach, transcatheter aortic valve implantation

    DOI

    https://doi.org/10.15836/ccar2024.23

    Full Text

    Aortic disease is the most common form of heart valve disease in developed countries, affecting 3% of the world’s population over the age of 65. The standard method of treating a symptomatic patient is surgical replacement of the valve. In patients with a high risk for surgery, the valve is implanted in a minimally invasive way, with transcatheter approach. (1, 2) This paper will present the success of treating aortic valve disease using the transcatheter method. Due to possibility of implantation via both transapical and transfemoral approaches, the patients featured in this study received valves manufactured by Edwards Lifesciences. We will also present the tasks of the nurse in preparing the patient, the operating room, and the valve itself. The obtained results of this research led to the conclusion that, apart from the duration of hospitalization, there was no statistically significant difference between the transcatheter aortic valve implantation (TAVI) procedure performed with transfemoral approach versus transapical approach at University Hospital Centre Rijeka. The duration of hospitalization in average is significantly shorter in patients who underwent TAVI procedure with transfemoral approach. The condition of the patients according to the New York Heart Association Classification significantly improved in both groups, there was no difference between the groups.

    Literature

    1. Back M, Larsson SC. Risk factors for aortic stenosis. e-Journal Of Cardiology Practice. 2020;18(11). (September 20, 2023). https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-18/risk-factors-for-aortic-stenosis
    2. Baman JR, Sekhon S, Flaherty JD. What Is Aortic Stenosis? JAMA. 2022 March 8;327(10):1003. https://doi.org/10.1001/jama.2022.0332
    Cardiologia Croatica
    Back to search

    Transcatheter implantation of the aortic valve: transfemoral and transapical approach

    Extended Abstract
    Issue1-2
    Published
    Pages23
    PDF via DOIhttps://doi.org/10.15836/ccar2024.23
    aortic disease
    transapical approach
    transfemoral approach
    transcatheter aortic valve implantation

    Authors

    Marko Gatarić*ORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Lea SaftićORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Katarina MatkovićORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Nikica PrpićORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Ivan ŠragaljORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia

    *Correspondence email: markogataric95@gmail.com

    Full Text

    Aortic disease is the most common form of heart valve disease in developed countries, affecting 3% of the world’s population over the age of 65. The standard method of treating a symptomatic patient is surgical replacement of the valve. In patients with a high risk for surgery, the valve is implanted in a minimally invasive way, with transcatheter approach. (1, 2) This paper will present the success of treating aortic valve disease using the transcatheter method. Due to possibility of implantation via both transapical and transfemoral approaches, the patients featured in this study received valves manufactured by Edwards Lifesciences. We will also present the tasks of the nurse in preparing the patient, the operating room, and the valve itself. The obtained results of this research led to the conclusion that, apart from the duration of hospitalization, there was no statistically significant difference between the transcatheter aortic valve implantation (TAVI) procedure performed with transfemoral approach versus transapical approach at University Hospital Centre Rijeka. The duration of hospitalization in average is significantly shorter in patients who underwent TAVI procedure with transfemoral approach. The condition of the patients according to the New York Heart Association Classification significantly improved in both groups, there was no difference between the groups.

    Literature

    1. 1.
      Back M, Larsson SC. Risk factors for aortic stenosis. e-Journal Of Cardiology Practice. 2020;18(11). (September 20, 2023).Link
    2. 2.
      Baman JR, Sekhon S, Flaherty JD. What Is Aortic Stenosis? JAMA. 2022 March 8;327(10):1003.DOI